Keywords
1. GeneSurrounder
2. Network-based analysis
3. Disease-associated genes
4. Transcriptomic data analysis
5. Pathway network integration
In the multidisciplinary field of bioinformatics, where biology intersects with computer science and mathematics, researchers aim to parse complex biological data, discover patterns, and elucidate the mechanisms underlying health and disease. A defining challenge in this field is the identification of genes that are associated with diseases from mountains of expression data. With the advent of GeneSurrounder, a new analytical method introduced by Sahil D. Shah and Rosemary Braun from Northwestern University (Shah et al., 2019), scientists have been equipped with a powerful tool that leverages both gene expression data and network information. This article delves into the transformative potential of GeneSurrounder in identifying disease genes and its implications for understanding the complex interplay of genetic regulation in cellular processes.
GeneSurrounder, designed to execute in R, an open-source programming language and environment for statistical computing, is available on GitHub at github.com/sahildshah1/gene-surrounder. This novel analysis method is grounded in the integration of transcriptomic data with regulatory network information to score and pinpoint genes that contribute significantly to network dysregulation. GeneSurrounder moves beyond the broad stroke approaches that yield unwieldy gene sets, refining the focus to driving forces in the network – a feature critical for targeting potential therapeutic interventions (DOI: 10.1186/s12859-019-2829-y).
When applied to actual expression data sets, GeneSurrounder not only surfaced biologically pertinent genes but managed to interlace pathway and expression details, showcasing reproducibility across multiple studies examining the same phenotype – a leap beyond the capabilities of existing methods. These findings uncover a fresh avenue for identifying individual genes warranted for therapeutic targeting and provide a more systematic approach to narrowing down genes for further experimental scrutiny.
A Networked Approach to Disease Gene Identification
The central innovation of GeneSurrounder is its scoring mechanism that relies on a gene’s ability to influence the dysregulation of its network neighbors, thus affecting cellular operation. Such a network-based perspective is crucial because genes do not operate in isolation; they form part of complex interaction networks that control various biological processes (Ritchie et al., 2015).
Previous methods of analysis, including those that harness group-based approaches (Manoli et al., 2006) or signaling pathway impact analysis (Tarca et al., 2009), tended to identify large cohorts of related genes or overlooked the regulatory influence of genes on their networks. GeneSurrounder surmounts these limitations by specifically spotlighting genes that potentially catalyze dysregulation, presenting a more refined target list for future experimental validation.
Validating GeneSurrounder’s Efficacy
Shah and Braun demonstrated GeneSurrounder’s adeptness through its application to various expression data sets, which revealed genes of biological significance that other methods had not flagged (Khatri et al., 2012). This reaffirms the method’s robustness in uncovering key genes that could elucidate disease mechanisms and serve as diagnostic and therapeutic targets.
For instance, in comparative studies of expression data for a particular phenotype, GeneSurrounder remained consistent in the genes it identified – a striking result considering the often irreconcilable differences that arise when varying methods are applied to identical data sets (Braun & Shah, 2014). This reproducibility emphasizes GeneSurrounder’s potential as a dependable tool for disease gene identification.
Applications in Drug Target Discovery and Biological Insights
Key to the utility of GeneSurrounder is its implication in drug discovery. By highlighting genes that act as sources of dysregulation in networks, GeneSurrounder assists in pinpointing potential drug targets (Subramanian et al., 2005). This is particularly valuable in cases where phenotypic changes may not be attributed to single gene mutations but result from the cumulative effects of multiple gene interactions.
Furthermore, by providing insights into the underlying mechanisms of disease, GeneSurrounder has the capacity to aid in the development of novel diagnostic tools. The method could help filter through vast gene sets, identifying those most critically involved in disease progression or onset.
Impact and Future of GeneSurrounder
The implications of GeneSurrounder’s successful identification of disease-associated genes reach far. The approach holds the promise of refining the selection process of genes for experimental validation, saving time, and resources that may otherwise be invested in examining large, non-specific gene groups (Kanehisa et al., 2007). Additionally, its role in enhancing the understanding of disease mechanisms cannot be overstated, as it facilitates a more direct pathway to therapeutic discovery.
With the tool now made freely accessible to the scientific community, it is anticipated that its adoption will accelerate not only in disease gene research but also potentially in personalized medicine, where patient-specific network dysregulation could be analyzed to tailor precise interventions (Gu et al., 2012).
Concluding Remarks
The introduction of GeneSurrounder is a testament to the power of combining computational prowess with biological knowledge. By harnessing the complex interconnections intrinsic to gene regulatory networks, GeneSurrounder offers a sophisticated means to discern the fine threads of disease etiology. Its introduction marks a significant advancement in bioinformatics and embodies the innovative spirit driving the quest to solve the biological puzzles of our time.
It invites a future where the union of technological innovation and scientific inquiry shines light upon the nuanced genetic tapestries tied to human health, providing answers, and, more importantly, solutions to persistent challenges in the understanding and treatment of diseases.
References
Shah, S. D., & Braun, R. (2019). GeneSurrounder: network-based identification of disease genes in expression data. BMC Bioinformatics, 20(1). https://doi.org/10.1186/s12859-019-2829-y
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015). limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research, 43(7), e47–e47. https://doi.org/10.1093/nar/gkv007.
Manoli, T., Gretz, N., Gröne, H. J., Kenzelmann, M., Eils, R., & Brors, B. (2006). Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics, 22(20), 2500.
Khatri, P., Sirota, M., & Butte, A. J. (2012). Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges. PLoS Computational Biology, 8(2), e1002375. https://doi.org/10.1371/journal.pcbi.1002375.
Braun, R., & Shah, S. (2014). Network methods for pathway analysis of gene expression data. arXiv [q-bio.QM]. http://arxiv.org/abs/1411.1993.
Kanehisa, M., Araki, M., Goto, S., Hattori, M., Hirakawa, M., Itoh, M., Katayama, T., Kawashima, S., Okuda, S., Tokimatsu, T., Yamanishi, Y. (2007). KEGG for linking genomes to life and the environment. Nucleic Acids Research, 36(Database), D480–D484. https://doi.org/10.1093/nar/gkm882.
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., & Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences, 102(43), 15545–15550. https://doi.org/10.1073/pnas.0506580102.
Gu, Z., Liu, J., Cao, K., Zhang, J., & Wang, J. (2012). Centrality-based pathway enrichment: a systematic approach for finding significant pathways dominated by key genes. BMC Systems Biology, 6, 56. https://doi.org/10.1186/1752-0509-6-56.